Glycosphingolipid levels and glucocerebrosidase activity are altered in normal aging of mouse brain by Hallett, PJ, Huebecker, M, Brekk, ØR, Moloney, EB, Rocha, EM, Priestman, D, Platt, FM, Isacson, O

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease by Huebecker, M, Moloney, EB, van der Spoel, AC, Priestman, DA, Isacson, O, Hallett, PJ, Platt, FM

Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity by Brekk, OR, Korecka, JA, Crapart, CC, Huebecker, M, MacBain, ZK, Rosenthal, SA, Sena-Esteves, M, Priestman, D, Platt, F, Isacson, O, Hallett, PJ

Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons by Cronin, SJF, Yu, W, Hale, A, Licht-Mayer, S, Crabtree, MJ, Korecka, JA, Tretiakov, EO, Sealey-Cardona, M, Somlyay, M, Onji, M, An, M, Fox, JD, Turnes, BL, Gomez-Diaz, C, da Luz Scheffer, D, Cikes, D, Nagy, V, Weidinger, A, Wolf, A, Reither, H, Chabloz, A, Kavirayani, A, Rao, S, Andrews, N, Latremoliere, A, Costigan, M, Douglas, G, Freitas, FC, Pifl, C, Walz, R, Konrat, R, Mahad, DJ, Koslov, AV, Latini, A, Isacson, O, Harkany, T, Hallett, PJ, Bagby, S, Woolf, CJ, Channon, KM, Je, HS, Penninger, JM